$13.87
0.14[1.02%]
At close: Apr 25
$13.87
0[0.00%]
PreMarket: 4:39AM EDT
Teladoc Health
(NYSE:TDOC)Teladoc Health Stock (NYSE:TDOC), Analyst Ratings, Price Targets, Predictions
Teladoc Health Inc has a consensus price target of $37.03, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Needham, Truist Securities, and Cantor Fitzgerald on April 5, 2024, March 6, 2024, and February 29, 2024. With an average price target of $13 between Needham, Truist Securities, and Cantor Fitzgerald, there's an implied -6.27% downside for Teladoc Health Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Truist Securities
Cantor Fitzgerald
Leerink Partners
DA Davidson
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Teladoc Health
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/05/2024 | TDOC | Buy Now | Teladoc Health | $13.87 | — | Needham | Ryan MacDonald | — | Reiterates | → Hold | Get Alert |
| 03/06/2024 | TDOC | Buy Now | Teladoc Health | $13.87 | 22.57% | Truist Securities | Jailendra Singh | $23 → $17 | Maintains | Hold | Get Alert |
| 02/29/2024 | TDOC | Buy Now | Teladoc Health | $13.87 | 58.62% | Cantor Fitzgerald | Sarah James | → $22 | Initiates | → Overweight | Get Alert |
| 02/26/2024 | TDOC | Buy Now | Teladoc Health | $13.87 | 22.57% | Leerink Partners | Michael Cherny | → $17 | Initiates | → Market Perform | Get Alert |
| 02/21/2024 | TDOC | Buy Now | Teladoc Health | $13.87 | 29.78% | DA Davidson | Gil Luria | $22 → $18 | Maintains | Neutral | Get Alert |
| 02/21/2024 | TDOC | Buy Now | Teladoc Health | $13.87 | 36.99% | Citigroup | Daniel Grosslight | $21 → $19 | Maintains | Neutral | Get Alert |
| 02/21/2024 | TDOC | Buy Now | Teladoc Health | $13.87 | 80.25% | RBC Capital | Sean Dodge | $30 → $25 | Maintains | Outperform | Get Alert |
| 02/21/2024 | TDOC | Buy Now | Teladoc Health | $13.87 | 80.25% | Barclays | Steve Valiquette | $26 → $25 | Maintains | Overweight | Get Alert |
| 02/21/2024 | TDOC | Buy Now | Teladoc Health | $13.87 | 80.25% | Piper Sandler | Jessica Tassan | $30 → $25 | Maintains | Overweight | Get Alert |
| 02/21/2024 | TDOC | Buy Now | Teladoc Health | $13.87 | 101.87% | Canaccord Genuity | Richard Close | $34 → $28 | Maintains | Buy | Get Alert |
| 11/17/2023 | TDOC | Buy Now | Teladoc Health | $13.87 | 36.99% | JP Morgan | Lisa Gill | $33 → $19 | Maintains | Neutral | Get Alert |
| 10/25/2023 | TDOC | Buy Now | Teladoc Health | $13.87 | 116.29% | RBC Capital | Sean Dodge | $35 → $30 | Maintains | Outperform | Get Alert |
| 10/25/2023 | TDOC | Buy Now | Teladoc Health | $13.87 | 87.45% | Oppenheimer | Michael Wiederhorn | $35 → $26 | Maintains | Outperform | Get Alert |
| 10/23/2023 | TDOC | Buy Now | Teladoc Health | $13.87 | 51.41% | Citigroup | Daniel Grosslight | $29 → $21 | Maintains | Neutral | Get Alert |
| 10/20/2023 | TDOC | Buy Now | Teladoc Health | $13.87 | 51.41% | Citigroup | Daniel Grosslight | $29 → $21 | Maintains | Neutral | Get Alert |
| 09/25/2023 | TDOC | Buy Now | Teladoc Health | $13.87 | 101.87% | Truist Securities | Jailendra Singh | → $28 | Reiterates | Hold → Hold | Get Alert |
| 07/26/2023 | TDOC | Buy Now | Teladoc Health | $13.87 | 101.87% | Stephens & Co. | Jeff Garro | → $28 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/26/2023 | TDOC | Buy Now | Teladoc Health | $13.87 | 152.34% | RBC Capital | Sean Dodge | → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 07/26/2023 | TDOC | Buy Now | Teladoc Health | $13.87 | 109.08% | Citigroup | Daniel Grosslight | $31 → $29 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Teladoc Health (TDOC)?
The latest price target for Teladoc Health (NYSE: TDOC) was reported by Needham on April 5, 2024. The analyst firm set a price target for $0.00 expecting TDOC to fall to within 12 months (a possible -100.00% downside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Teladoc Health (TDOC)?
The latest analyst rating for Teladoc Health (NYSE: TDOC) was provided by Needham, and Teladoc Health reiterated their hold rating.
When was the last upgrade for Teladoc Health (TDOC)?
The last upgrade for Teladoc Health Inc happened on February 23, 2023 when SVB Leerink raised their price target to $34. SVB Leerink previously had a market perform for Teladoc Health Inc.
When was the last downgrade for Teladoc Health (TDOC)?
The last downgrade for Teladoc Health Inc happened on August 17, 2022 when Guggenheim changed their price target from N/A to $25 for Teladoc Health Inc.
When is the next analyst rating going to be posted or updated for Teladoc Health (TDOC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on April 5, 2024 so you should expect the next rating to be made available sometime around April 5, 2025.
Is the Analyst Rating Teladoc Health (TDOC) correct?
While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a reiterated with a price target of $0.00 to $0.00. The current price Teladoc Health (TDOC) is trading at is $13.87, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.